Skip to content

Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public

Tags · Sourcing

mislabelling

Wrong compound, wrong strength, or wrong batch on the label.

41 topics 15 solved Group: Sourcing

Sourcing 22 Compounds 19

Related in this group: certificate of analysis · batch & lot numbers · Janoshik Analytical · Medutest · PeptideMeter · VendorInvestigate · third-party testing · blind sampling · documentation quality · underdosing · customs · shipping

41 topics · page 2 of 2

Topic	Participants	Replies	Views	Activity
When "no data" is the complete and final answer Compounds › Other compounds custom synthesis mislabelling needs a source research use only Solved Asking directly, because I could not find a straight answer: When "no data" is the complete and final answer I have seen SURMOUNT-1 ( N Engl J Med , 2022) cited in support of a claim I do not think it…	+154	165	6.3k	15mo
A supplier who responds to a discrepancy with silence Sourcing › Red flags underdosing documentation quality moderation mislabelling Closed On the subject in the title: A supplier who responds to a discrepancy with silence Working notes rather than a conclusion. Structured report rather than an opinion, following the format the maintainers asked…		2	6.1k	16mo
Patterns that reliably precede a problem, documented Sourcing › Red flags documentation quality disputed mislabelling underdosing Patterns that reliably precede a problem, documented — setting out what I have, and where I think it stops being reliable. A logistics question, since the answers here are usually better than anywhere else I…	+3	7	31k	16mo
Research-use-only status: what it means legally and practically — a second dataset Compounds › Other compounds research use only mislabelling needs a source custom synthesis Solved Research-use-only status: what it means legally and practically — a second dataset — setting out what I have, and where I think it stops being reliable. Comparing FLOW ( N Engl J Med , 2024) with SURPASS-2 (…	+109	125	2k	16mo
About the Red flags category Sourcing › Red flags mislabelling underdosing documentation quality Pinned Wiki Closed Patterns that reliably precede a problem. Documented, dated, and free of accusation without evidence. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is…		4	57k	17mo
Identical chromatograms across two different lots Sourcing › Red flags mislabelling underdosing documentation quality Identical chromatograms across two different lots Writing it up because I had to work it out twice and would rather nobody else did. A logistics question, since the answers here are usually better than…	+80	87	58k	18mo
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Compounds › Other compounds custom synthesis mislabelling research use only Solved Posting this under the heading it deserves: Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Everything below is what sits behind that. Comparing SURMOUNT-4 ( JAMA , 2024) with…	+119	141	22k	20mo
Melanocortin agonists: mechanism and the documented adverse profile Compounds › Other compounds needs a source mislabelling research use only custom synthesis Melanocortin agonists: mechanism and the documented adverse profile — setting out what I have, and where I think it stops being reliable. Comparing STEP 4 ( JAMA , 2021) with SURMOUNT-2 ( Lancet , 2023) and…	+7	11	5.5k	20mo
When a red flag was a misunderstanding, and the retraction Sourcing › Red flags underdosing disputed mislabelling Pinned When a red flag was a misunderstanding, and the retraction — that is the question, and I have not found it answered plainly anywhere I have looked. I would like to talk about documentation quality as a…	+34	38	8.3k	21mo
Coming back to: Pricing far outside the range, in either direction Sourcing › Red flags documentation quality underdosing mislabelling Pricing far outside the range, in either direction Writing it up because I had to work it out twice and would rather nobody else did. Structured report rather than an opinion, following the format the…	+22	26	325	2y
Naming conventions for research peptides and the confusion they cause — one year on Compounds › Other compounds research use only mislabelling needs a source Naming conventions for research peptides and the confusion they cause — one year on — setting out what I have, and where I think it stops being reliable. I have seen SURMOUNT-2 ( Lancet , 2023) cited in…	+1	5	181	2y